The 5-year analysis of Nath Bio-Genes (India) Ltd's performance infers:
Nath Bio-Genes (India) Ltd earnings have grown by 10.8%, whereas share price has appreciated 31.3% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.